Market Overview:
The global intravenous injection immunoglobulin market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of autoimmune diseases, rising geriatric population, and growing demand for immunoglobulin therapies. Based on type, the global intravenous injection immunoglobulin market is segmented into 1g/20ml, 1.25g/25ml, 2.5g/50ml, 5g/100ml and 10g/200ml segments. The 1 g / 20 ml segment is expected to account for the largest share of the global intravenous injection immunoglobulin market in 2018 owing to its high usage in various applications such as hospital and clinic settings across different regions worldwide. However, with increasing demand for higher dosages of Immunoglobulins (Igs), especially in developed countries such as North America and Europe ,the 2 .5 g / 50 ml segment is projected to register highest CAGR during the forecast period from 2018-2030 . Based on application ,the global intravenous injection immunoglobulin market is divided into three segments namely hospitals , clinics and others which include research institutes & biotechnology companies among others .
Product Definition:
Intravenous Injection Immunoglobulin (IVIg) is a therapy that uses antibodies from donated blood to help improve the immune system. IVIg is used to treat certain diseases or conditions that affect the immune system, such as primary immunodeficiency, autoimmune disorders, and chronic inflammation.
1g/20ml:
1g/20ml is the standard concentration for intravenous immunoglobulin. It's used to treat a variety of immune system disorders, including primary immune deficiency and secondary immune deficiency. The treatment is usually given by IV infusion every 8-16 weeks depending on the type of disorder being treated.
Increasing prevalence rate of various diseases such as HIV AIDS.
1.25g/25ml:
1.25g/25ml is a unit dose container used for the storage and dispensing of intravenous immunoglobulin (IVIG). It is available in pre-filled syringes or vials containing 0.9% sodium chloride solution, which helps reduce preparation time by approximately 50%. The product also offers convenience to patients as it eliminates manual weighing and clean up time after each use.
Application Insights:
The others application segment held the largest share of 66.1% in 2017 owing to the growing number of patients suffering from chronic diseases such as diabetes and autoimmune disorders. These patients require regular injections, which leads to high demand for IVIG treatments across clinics and hospitals. Moreover, increasing research & development activities by major players for introduction of novel products is expected to create growth opportunities in near future. This will lead to higher penetration and adoption of IVIG treatment options among other applications during the forecast period.
Clinic application accounted for a significant share due largely to factors such as rising awareness about immunoglobulin therapy among clinicians, availability of advanced equipment at low cost, government initiatives that support accessibility along with an increase in patient visits due largely to travel related infections that are on rise globally especially amongst children & elderly people is expected fuel demand over the forecast period (Global Intravenous Injection Immunoglobulin (IVIG) market by application, 2016).
Regional Analysis:
Europe dominated the global market in 2017 owing to the presence of a large number of manufacturers and distributors. The region is expected to maintain its dominance over the forecast period due to growing cases of immune disorders, increasing R&D expenditure by companies, and rising awareness about intravenous immunoglobulin therapies.
Asia Pacific is anticipated to be fastest-growing regional market from 2018 to 2030 due for instance increased healthcare spending by governments along with rising awareness about IVIG therapy among patients suffering from autoimmune diseases such as lupus & rheumatoid arthritis. Moreover, increasing incidence rate of Type 1 diabetes has also led major players in this region focus on developing products that can treat diabetic complications such as blindness, kidney failure etc., which will drive growth further.
Growth Factors:
- Increasing incidence of autoimmune diseases: The increasing incidence of autoimmune diseases is one of the key growth drivers for the intravenous injection immunoglobulin market. Immunoglobulins are used to treat a wide range of autoimmune diseases, which is expected to drive the demand for these products in the coming years.
- Growing awareness about IVIg therapy: There is a growing awareness about IVIg therapy among healthcare professionals and patients alike. This is likely to boost demand for these products in the coming years.
- Rising number of approved indications: The number of approved indications for intravenous injection immunoglobulin therapies continues to grow, providing a major impetus to market growth. Intravenous injection immunoglobulin therapies are now approved for use in a wide range of conditions, including primary immune deficiencies, Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN).
- Technological advancements: The development and commercialization of new intravenous injection immunoglobulin therapies has been propelled by technological advancements in this area over the past few years. This has led to an increase in product options available to patients and healthcare professionals alike, boosting market growth prospects going forward . 5) Expanding patient population: The expanding patient population due to rising prevalence ratesof various chronic disorders is another key factor that will fuel demandfor intraven
Scope Of The Report
Report Attributes
Report Details
Report Title
Intravenous Injection Immunoglobulin Market Research Report
By Type
1g/20ml, 1.25g/25ml, 2.5g/50ml, 5g/100ml, 10g/200ml
By Application
Hospital, Clinic, Others
By Companies
Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, Weiguang Biological, Sinopharm, Shanghai RAAS, CTBB, Nanyue Biopharming
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
178
Number of Tables & Figures
125
Customization Available
Yes, the report can be customized as per your need.
Global Intravenous Injection Immunoglobulin Market Report Segments:
The global Intravenous Injection Immunoglobulin market is segmented on the basis of:
Types
1g/20ml, 1.25g/25ml, 2.5g/50ml, 5g/100ml, 10g/200ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boya-Bio
- Beijing Tiantan Biological Products
- Hualan Bio
- Guangdong Shuagnlin Bio-pharmacy
- Weiguang Biological
- Sinopharm
- Shanghai RAAS
- CTBB
- Nanyue Biopharming
Highlights of The Intravenous Injection Immunoglobulin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1g/20ml
- 1.25g/25ml
- 2.5g/50ml
- 5g/100ml
- 10g/200ml
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intravenous Injection Immunoglobulin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intravenous injection immunoglobulin (IVIG) is a form of medication that helps the body fight infections. IVIG is given through a vein, and it can help treat certain types of immune system problems.
Some of the key players operating in the intravenous injection immunoglobulin market are Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, Weiguang Biological, Sinopharm, Shanghai RAAS, CTBB, Nanyue Biopharming.
The intravenous injection immunoglobulin market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intravenous Injection Immunoglobulin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intravenous Injection Immunoglobulin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intravenous Injection Immunoglobulin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intravenous Injection Immunoglobulin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intravenous Injection Immunoglobulin Market Size & Forecast, 2018-2028
4.5.1 Intravenous Injection Immunoglobulin Market Size and Y-o-Y Growth
4.5.2 Intravenous Injection Immunoglobulin Market Absolute $ Opportunity
Chapter 5 Global Intravenous Injection Immunoglobulin Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Intravenous Injection Immunoglobulin Market Size Forecast by Type
5.2.1 1g/20ml
5.2.2 1.25g/25ml
5.2.3 2.5g/50ml
5.2.4 5g/100ml
5.2.5 10g/200ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Intravenous Injection Immunoglobulin Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Intravenous Injection Immunoglobulin Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intravenous Injection Immunoglobulin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intravenous Injection Immunoglobulin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Intravenous Injection Immunoglobulin Analysis and Forecast
9.1 Introduction
9.2 North America Intravenous Injection Immunoglobulin Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Intravenous Injection Immunoglobulin Market Size Forecast by Type
9.6.1 1g/20ml
9.6.2 1.25g/25ml
9.6.3 2.5g/50ml
9.6.4 5g/100ml
9.6.5 10g/200ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Intravenous Injection Immunoglobulin Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Intravenous Injection Immunoglobulin Analysis and Forecast
10.1 Introduction
10.2 Europe Intravenous Injection Immunoglobulin Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Intravenous Injection Immunoglobulin Market Size Forecast by Type
10.6.1 1g/20ml
10.6.2 1.25g/25ml
10.6.3 2.5g/50ml
10.6.4 5g/100ml
10.6.5 10g/200ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Intravenous Injection Immunoglobulin Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Intravenous Injection Immunoglobulin Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Intravenous Injection Immunoglobulin Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Intravenous Injection Immunoglobulin Market Size Forecast by Type
11.6.1 1g/20ml
11.6.2 1.25g/25ml
11.6.3 2.5g/50ml
11.6.4 5g/100ml
11.6.5 10g/200ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Intravenous Injection Immunoglobulin Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Intravenous Injection Immunoglobulin Analysis and Forecast
12.1 Introduction
12.2 Latin America Intravenous Injection Immunoglobulin Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Intravenous Injection Immunoglobulin Market Size Forecast by Type
12.6.1 1g/20ml
12.6.2 1.25g/25ml
12.6.3 2.5g/50ml
12.6.4 5g/100ml
12.6.5 10g/200ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Intravenous Injection Immunoglobulin Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Intravenous Injection Immunoglobulin Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Intravenous Injection Immunoglobulin Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Intravenous Injection Immunoglobulin Market Size Forecast by Type
13.6.1 1g/20ml
13.6.2 1.25g/25ml
13.6.3 2.5g/50ml
13.6.4 5g/100ml
13.6.5 10g/200ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Intravenous Injection Immunoglobulin Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intravenous Injection Immunoglobulin Market: Competitive Dashboard
14.2 Global Intravenous Injection Immunoglobulin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boya-Bio
14.3.2 Beijing Tiantan Biological Products
14.3.3 Hualan Bio
14.3.4 Guangdong Shuagnlin Bio-pharmacy
14.3.5 Weiguang Biological
14.3.6 Sinopharm
14.3.7 Shanghai RAAS
14.3.8 CTBB
14.3.9 Nanyue Biopharming
